Lynparza® (Olaparib) – Targeted Cancer Treatment
Lynparza® (olaparib) is an oral medication used to treat cancers linked to specific genetic mutations, including ovarian, breast, pancreatic, and prostate cancers. It is particularly effective in patients with BRCA1 and BRCA2 mutations, as it targets the PARP enzyme involved in DNA repair. By blocking DNA repair in cancer cells, Lynparza helps to slow tumor growth and improve outcomes.
Key Benefits:
- Targeted Action: Specifically designed to target cancer cells with genetic mutations, improving treatment precision.
- Oral Treatment: Easy-to-take pill form for convenient daily use.
- Proven Efficacy: Shown to delay cancer progression in patients with BRCA mutations.
Indications:
Lynparza is used for treating:
- Ovarian, breast, pancreatic, and prostate cancers with specific genetic mutations.
How It Works:
Lynparza inhibits the PARP protein, which cancer cells need to repair DNA. This makes it harder for the cancer cells to survive and grow, particularly in those with existing DNA repair deficiencies.
Important Information:
- Side Effects: May include nausea, fatigue, and low blood counts.
- Consult your doctor to see if Lynparza is right for you.
Reviews
There are no reviews yet.